Series B funding round for Aeglea BioTherapeutics raising $44M in March 2015
Series B funding round for Aeglea BioTherapeutics raising $44M in March 2015
| Investor | Firm Type | Partner |
|---|
NovartisLEAD | Private | — |
Lilly VenturesLEAD | Venture Capital | — |
| Private | — | |
| Private | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Private | — | |
| Venture Capital | — | |
| Private | — |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$56M
Top Valuation
-
Aeglea BioTherapeutics raised $44M in a Series B round.
The round was announced on 03/01/15.
The round was led by Armen Shanafelt, Novartis.